|
|
|
|
| Top Story |
 |
|
Hope for Innovation Support in Europe |
The 2017 EU State of the Union address contained more than a few nuggets that drug industry strategists are now starting to take seriously—aided by a few injections of real money too. Reflector reports
... /Read more/ |
|
|
|
| Calendar |
|
/ October 24–25: 12th Annual Value-Based Oncology Management / |
|
Scottsdale, AZ |
|
/ October 26–27: MedComm / |
|
San Francisco, CA |
|
/ November 14: EU GDPR Bootcamp Life Sciences / |
|
London, UK |
|
/ November 15-16: 4th Annual Global Compliance Congress for Life Sciences / |
|
London, UK |
|
/ November 28–29: Commercial Data Insights / |
|
Philadelphia, PA |
|
/ December 4–5: Connected Devices in Healthcare / |
|
San Diego, CA |
|
/ February 7–8, 2018: Speaker Programs 2018 / |
|
Philadelphia, PA |
|
/ March 25–28, 2018: 14th Annual Pharma Forum / |
|
Philadelphia, PA |
|
|
|
| Industry update |
| //Atlas Genetics (Bath, UK) appointed Jeffrey R. Luber as Chief Executive Officer. //Gyroscope Therapeutics (London, UK) appointed Dr. Soraya Bekkali as Chief Executive Officer and Director of its Board. //Novo Holdings (Hellerup, Denmark) elected Jean-Luc Butel, Senior Advisor at McKinsey & Company Healthcare Systems & Services, and Francis Cuss, former Executive Vice President and Chief Scientific Officer of Bristol-Myers Squibb, to its Board of Directors. //InGeneron (Houston, TX, and Munich, Germany) announced that Angelo Moesslang, Ph.D, former Chief Financial Officer of Fresenius Medical Care North America, joined as Chief Executive Officer. //
|
|
|
|
